Abpro (ABP) Competitors $0.19 0.00 (-2.49%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ABP vs. CUE, KLRS, RENB, VRCA, HOWL, BLUE, IPA, IPSC, RNXT, and VTVTShould you be buying Abpro stock or one of its competitors? The main competitors of Abpro include Cue Biopharma (CUE), Kalaris Therapeutics (KLRS), Renovaro (RENB), Verrica Pharmaceuticals (VRCA), Werewolf Therapeutics (HOWL), bluebird bio (BLUE), ImmunoPrecise Antibodies (IPA), Century Therapeutics (IPSC), RenovoRx (RNXT), and vTv Therapeutics (VTVT). These companies are all part of the "pharmaceutical products" industry. Abpro vs. Its Competitors Cue Biopharma Kalaris Therapeutics Renovaro Verrica Pharmaceuticals Werewolf Therapeutics bluebird bio ImmunoPrecise Antibodies Century Therapeutics RenovoRx vTv Therapeutics Cue Biopharma (NASDAQ:CUE) and Abpro (NASDAQ:ABP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk. Do insiders & institutionals have more ownership in CUE or ABP? 35.0% of Cue Biopharma shares are owned by institutional investors. Comparatively, 23.3% of Abpro shares are owned by institutional investors. 10.8% of Cue Biopharma shares are owned by company insiders. Comparatively, 20.8% of Abpro shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to CUE or ABP? In the previous week, Cue Biopharma had 1 more articles in the media than Abpro. MarketBeat recorded 4 mentions for Cue Biopharma and 3 mentions for Abpro. Cue Biopharma's average media sentiment score of 0.61 beat Abpro's score of 0.00 indicating that Cue Biopharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cue Biopharma 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Abpro 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, CUE or ABP? Abpro has lower revenue, but higher earnings than Cue Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCue Biopharma$9.29M5.58-$40.67M-$0.67-1.03Abpro$183K62.45-$7.23MN/AN/A Is CUE or ABP more profitable? Abpro has a net margin of 0.00% compared to Cue Biopharma's net margin of -507.87%. Abpro's return on equity of 0.00% beat Cue Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Cue Biopharma-507.87% -228.43% -114.66% Abpro N/A N/A -198.95% Do analysts prefer CUE or ABP? Cue Biopharma currently has a consensus price target of $3.00, indicating a potential upside of 336.05%. Abpro has a consensus price target of $4.00, indicating a potential upside of 2,027.66%. Given Abpro's higher possible upside, analysts clearly believe Abpro is more favorable than Cue Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cue Biopharma 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Abpro 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryCue Biopharma and Abpro tied by winning 6 of the 12 factors compared between the two stocks. Get Abpro News Delivered to You Automatically Sign up to receive the latest news and ratings for ABP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABP vs. The Competition Export to ExcelMetricAbproMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.43M$2.91B$5.54B$9.05BDividend YieldN/A2.44%5.24%4.02%P/E RatioN/A21.5627.4320.23Price / Sales62.45281.76422.11118.64Price / CashN/A42.7336.8958.07Price / Book-0.657.518.045.67Net Income-$7.23M-$55.05M$3.18B$249.13M7 Day Performance-10.90%4.61%2.89%3.28%1 Month Performance-11.45%4.72%3.70%5.56%1 Year PerformanceN/A5.92%36.15%21.12% Abpro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABPAbproN/A$0.19-2.5%$4.00+2,027.7%N/A$11.43M$183K0.0015CUECue Biopharma4.1053 of 5 stars$0.67-1.5%$3.00+346.2%-29.8%$51.41M$9.29M-1.0060News CoverageKLRSKalaris TherapeuticsN/A$2.58-3.4%N/AN/A$49.94MN/A0.00110Positive NewsGap UpRENBRenovaro1.1737 of 5 stars$0.27-5.8%N/A-82.4%$49.72MN/A-0.3520Gap UpVRCAVerrica Pharmaceuticals3.9269 of 5 stars$0.60+13.4%$8.00+1,231.1%-90.8%$49.03M$7.57M-0.5040High Trading VolumeHOWLWerewolf Therapeutics3.1032 of 5 stars$1.05-3.7%$8.33+693.7%-49.5%$48.91M$1.88M-0.6340News CoveragePositive NewsBLUEbluebird bio2.1495 of 5 stars$4.97flat$44.60+797.4%N/A$48.67M$103.95M-0.13520News CoverageIPAImmunoPrecise Antibodies1.7718 of 5 stars$1.09+2.8%$4.00+267.0%+33.5%$48.51M$18.16M-0.9480News CoverageIPSCCentury Therapeutics2.77 of 5 stars$0.54-2.8%$4.20+673.5%-75.3%$48.14M$6.59M-1.87170RNXTRenovoRx2.8872 of 5 stars$1.27-3.4%$7.25+470.9%+20.5%$48.09M$40K-3.186Gap DownVTVTvTv Therapeutics1.8962 of 5 stars$14.67-2.2%$35.50+142.0%-26.0%$47.92M$1.02M-4.879 Related Companies and Tools Related Companies CUE Alternatives KLRS Alternatives RENB Alternatives VRCA Alternatives HOWL Alternatives BLUE Alternatives IPA Alternatives IPSC Alternatives RNXT Alternatives VTVT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABP) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abpro Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abpro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
